Showing results (41-50 of 81) with videos related to

Sort By:
Pageof 9
Journal of Immunological Methods|November 27, 1998
A sandwich type acridinium-linked immunosorbent assay (ALISA) detects soluble ErbB1 (sErbB1) in normal human seraA T Baron, J M Lafky, D C Connolly, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|November 9, 2001
A preliminary study of serum concentrations of soluble epidermal growth factor receptor (sErbB1), gonadotropins, and steroid hormones in healthy men and womenA T Baron, J M Lafky, V J Suman, et al.
The Annals of Pharmacotherapy|August 4, 2001
Use of antihypertensive and antithrombotic medications after stroke in community-based careS K Rigler, M J Webb, A T Patel, et al.
Journal of the National Cancer Institute|December 1, 1977
Phase II evaluation of cytembena (NSC-104801) in patients with advanced ovarian carcinoma resistant to alkylating agents: brief communicationJ H Edmonson, D G Decker, G D Malkasian, et al.
Anticancer Research|May 1, 1994
Detection of p53 antigen expression in cytologic preparations of ovarian carcinomasT K Cheung, J M Cunningham, M J Webb, et al.
Journal of the American Geriatrics Society|February 24, 2001
Weight outcomes among antidepressant users in nursing facilitiesS K Rigler, M J Webb, L Redford, et al.
Gynecologic Oncology|January 4, 2001
Gastrointestinal surgery in patients with ovarian cancerK F Tamussino, P C Lim, M J Webb, et al.
American Journal of Obstetrics and Gynecology|June 28, 2000
Low-risk corpus cancer: is lymphadenectomy or radiotherapy necessary?A Mariani, M J Webb, G L Keeney, et al.
European Journal of Cancer & Clinical Oncology|June 1, 1987
Predictive value of serial CA 125 antigen levels in ovarian cancer evaluated by second-look laparotomyS K Khoo, T Hurst, M J Webb, et al.
Pageof 9